Literature DB >> 3198609

Spontaneous peptide bond cleavage in aging alpha-crystallin through a succinimide intermediate.

C E Voorter1, W A de Haard-Hoekman, P J van den Oetelaar, H Bloemendal, W W de Jong.   

Abstract

Cleavage of specific peptide bonds occurs with aging in the alpha A subunit of bovine alpha-crystallin. One of the breaks occurs at residue Asn-101. This same residue undergoes in vivo deamidation, isomerization, and racemization. Deamidation and isomerization are known to occur via succinimide ring formation of labile asparagine residues. Model studies on peptides have shown that imide formation can also lead to peptide bond cleavage (Geiger, T., and Clarke, S. (1987) J. Biol. Chem. 262, 785-794). In that case, both asparagine and aspartic acid amide would be expected as C termini of the truncated polypeptide, and this is indeed the case in the alpha A-(1-101)-chain. This thus represents a first example of nonenzymatic in vivo peptide bond cleavage in an aging protein through the formation of a succinimide intermediate. In addition, we found that in bovine lens no detectable conversion (through the action of protein-carboxyl methyltransferase) of isoaspartyl to normal aspartyl residues occurs in vivo after deamidation of Asn-101.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198609

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  The effects of alpha-helix on the stability of Asn residues: deamidation rates in peptides of varying helicity.

Authors:  A A Kosky; U O Razzaq; M J Treuheit; D N Brems
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.

Authors:  K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 3.  Virus maturation.

Authors:  David Veesler; John E Johnson
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

4.  Large-scale, pH-dependent, quaternary structure changes in an RNA virus capsid are reversible in the absence of subunit autoproteolysis.

Authors:  Derek J Taylor; Neel K Krishna; Mary A Canady; Anette Schneemann; John E Johnson
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to site-specific substrate deamidation.

Authors:  Edward J Dudek; Kirsten J Lampi; Jason A Lampi; Fu Shang; Jonathan King; Yongting Wang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

Review 6.  The etiology of human age-related cataract. Proteins don't last forever.

Authors:  Roger J W Truscott; Michael G Friedrich
Journal:  Biochim Biophys Acta       Date:  2015-08-28

7.  Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.

Authors:  June Kuang; Yuanqi Tao; Yuanli Song; Letha Chemmalil; Nesredin Mussa; Julia Ding; Zheng Jian Li
Journal:  Anal Bioanal Chem       Date:  2021-02-05       Impact factor: 4.142

8.  The l-isoaspartate modification within protein fragments in the aging lens can promote protein aggregation.

Authors:  Rebeccah A Warmack; Harrison Shawa; Kate Liu; Katia Lopez; Joseph A Loo; Joseph Horwitz; Steven G Clarke
Journal:  J Biol Chem       Date:  2019-06-25       Impact factor: 5.157

9.  Racemization of two proteins over our lifespan: deamidation of asparagine 76 in γS crystallin is greater in cataract than in normal lenses across the age range.

Authors:  Michelle Yu Sung Hooi; Mark J Raftery; Roger John Willis Truscott
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-14       Impact factor: 4.799

10.  A density functional theory study on peptide bond cleavage at aspartic residues: direct vs cyclic intermediate hydrolysis.

Authors:  Wichien Sang-aroon; Vittaya Amornkitbamrung; Vithaya Ruangpornvisuti
Journal:  J Mol Model       Date:  2013-11-17       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.